qcom eli lilly - Search News

News

Eli Lilly, Daily Pill and Weight Loss

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

Investopedia on MSN · 11h

Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results

Shares of Eli Lilly jumped 12% in premarket trading Thursday after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that "demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.

Insider on MSN · 10h

Eli Lilly finds its weight-loss pill works just as well as Ozempic — and investors are loving it

The positive data gives Eli Lilly the green light to file the drug with the FDA by the end of the year for a weight loss indication.

Hosted on MSN1mon

Why QUALCOMM Incorporated (QCOM) is the Best Virtual Reality Stock to Buy According to Analysts

Here is what the fund said: “Alphabet Inc., Eli Lilly and Company, QUALCOMM Incorporated (NASDAQ:QCOM), Microsoft Corporation, and Apple Inc. were the largest detractors. Qualcomm has given back ...

Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Eli Lilly, Daily Pill and Weight Loss

Trending now